close
  • home Home

  • linked_services Solutions keyboard_arrow_down

  • experiment Services keyboard_arrow_down

  • support Support & Resources keyboard_arrow_down

  • apartment Company keyboard_arrow_down

  • mail Contact

  • Solutions
    keyboard_arrow_down
  • Services
    keyboard_arrow_down
  • Support & Resources
    keyboard_arrow_down
  • Company
    keyboard_arrow_down
  • Contact
Randox Health search menu
Three Acusera quality control bottles with colored caps and numbered labels for lab diagnostics.

The Randox Acusera HbA1c control is designed for use in the quality control of HbA1c assays. Assayed instrument and method specific target values and ranges are provided for all major systems and methods including HPLC. A reconstituted stability of 4 weeks keeps waste to a minimum and helps to reduce costs.

Get in touch to discover more

To find out more about this Acusera Control or to get in touch. with your local Randox Representative, enquire now.

Features & Benefits - Control

  • Lyophilised for enhanced stability.
  • 100% human whole blood.
  • Assayed target values provided for 2 parameters.
  • Conveninet bi-level pack containing two clinically significant levels of control
  • Stable to expiry date at 2°C to 8°C.
  • Reconstituted stability of 4 weeks at 2°C to 8°C.

Features & Benefits - Calibrator

  • Lyophilised for enhanced stability.
  • 100% human whole blood.
  • Stable to expiry date at 2ºC to 8ºC.
  • Reconstituted stability of 14 days at 2ºC to 8ºC.
  • Multi-point calibrator.
  • Traceable to NGSP.
DescriptionSizeCat No
HbA1c Control Set Level 1 and 22 x 2 x 0.5 mlHA5072EnquireSearch Kit InsertsView MSDSBuy Online
HbA1c II Calibrator Series5 x 0.5 mlHA8124EnquireSearch Kit InsertsView MSDSBuy Online

Analytes

  • HbA1c
  • Total Haemoglobin
SMARTDOCS
One location for all Randox Quality Control products inserts.
Acusera Brochure
True third party controls offering complete test menu consolidation
RIQAS External Quality Assessment
The largest international EQA Scheme with over 76,000 Laboratory Participants.